| Literature DB >> 30729925 |
Shivangi Gupta1, Robin Sabharwal2, Jazib Nazeer3, Lavina Taneja4, Basanta Kumar Choudhury5, Sudipta Sahu6.
Abstract
Background: The overall success of dental implants depends on the crestal bone support around the implants. During the initial years of dental implant placement, the bone loss around the implants determines the success rate of treatment. Platform switching (PLS) concept preserves the crestal bone loss, and this approach should be applied clinically for the overall success of dental implants. Purpose: The purpose of this study is to discuss the literature dealing with the concept of PLS concept and preservation of marginal bone, the mechanism by which it contributes to maintenance of marginal bone, its clinical applications, advantages, and disadvantages, to assess its survival rates. Materials andEntities:
Keywords: Crestal bone; dental implants; platform switching
Mesh:
Substances:
Year: 2019 PMID: 30729925 PMCID: PMC6380118 DOI: 10.4103/aam.aam_15_18
Source DB: PubMed Journal: Ann Afr Med ISSN: 0975-5764
Studies relating the platform switching and bone loss
| Authors published year | Number of patients age (mean±SD) | Number of implant (control) | Type of implant (manufacture) | Bone resorption/bone change (unit: mm) |
|---|---|---|---|---|
| PLS (abutment/implant) unit: mm | ||||
| Gender ratio | ||||
| Canullo | 22 | 22 (11) | Global implant (Sweden and Martina) | Test: overall: 0.3±0.157 |
| 50±14.46 | ||||
| 13 male, 9 female | M: 0.25±0.123 (0.07-0.47) | |||
| 5.5/5.5 | ||||
| 3.8/5.5 | D: 0.36±0.157 (0.09-0.8) | |||
| Control: Overall: 1.19±0.138 | ||||
| M: 1.13±1.25 (0.58-1.85) | ||||
| D: 1.25±0.404 (0.62-1.8) | ||||
| Calvo-Guirado | 50 | 61 (no control) | Certain Prevail (Biomet 3i) | M: 0.08±0.53 |
| 4.1/4.8 | D: 0.09±0.65 | |||
| 39.64±6.06 | ||||
| 25 male, 25 female | ||||
| Prosper | 60 | 360 (180) | Winxix (Winxix Ltd) | Percentage of implants with no crestal bone loss: (test vs. control) |
| 53.9±6.8 | 3.3/3.8 | |||
| 12 months: 98.3% versus 66.1% | ||||
| 32 male, 28 Female | 3.8/4.5 | ( | ||
| Rodríguez-Ciurana | 37 | 82 (no control) | Certain Prevail (Biomet 3i) | M: 0.7±0.57 |
| No data | 4.1/4.8 | D: 0.55±0.52 | ||
| 5.0/5.8 | ||||
| 17 male, 20 female | 4.1/5.0 | |||
| 3.4/4.1 | ||||
| Calvo Guirado | 18 | 105 (no control) | Certain Prevail (Biomet 3i) | 0.6±1.0 (−2.6-0.8) |
| 55.97±7.25 | 4.1/4.8 | |||
| 3 male, 15 female | 4.1/5 | |||
| Cappiello | 45 | 131 (56) | Certain Prevail (Biomet 3i) | Test: 1.05±0.22 |
| Control: 1.78±026 | ||||
| No data | 4.1/4.8 | Bone loss: Test: 0.95±0.32 (0.6-1.2) | ||
| No data | 4.1/4.1 | Control: 1.67±0.37 (1.3-2.1) | ||
| Canullo and Rasperini[ | 9 | 10 (no control) | 10 (no control) TSATM Series | M 0.57 (0.002±1.02) |
| 45.9 | 5 Defcon (defcon | D 1.01 (0.230±1.592) | ||
| implant system) | ||||
| 2 male, 7 female | 4.0/6.0 | |||
| Hürzeler | 15 | 22 (8) | Osseotite External | Bone level change (base line-12 months) |
| 55.3 | HEX (Biomet 3i) | |||
| 7 male, 8 female | Test: −0.09±0.65−0.22±0.53 | |||
| 4.1/5.0 | Mean: −0.12±0.40 | |||
| Control: −1.73±0.4−2.02±0.49 | ||||
| 4.1/4.1 | ||||
| Calvo Guirado | 10 | 10 (no control) | Certain Prevail (Biomet 3i) | Mean bone loss |
| No data | 4.1/4.8 | Central incisor: M 0.05, D 0.07 | ||
| 3 male, 7 female | 3.8/4.1 | Lateral incisor: M 0.07, D 0.06 | ||
| Overall: Less 1.0 mm |
PLS=Platform switching, SD=Standard deviation